Trials / Terminated
TerminatedNCT00970606
STIP: Statin Trial for Influenza Patients
Randomized, Placebo Controlled Trial of the Effectiveness of Statins for Preventing Mortality Following ICU Admission for Influenza Complications
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Gordon Bernard · Academic / Other
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Not accepted
Summary
To assess the efficacy and safety of oral rosuvastatin in patients with suspected or confirmed influenza who require intensive care unit (ICU) admission due to respiratory distress.
Detailed description
Hypothesis: Rosuvastatin therapy will improve mortality and reduce the need for mechanical ventilation in patients experiencing respiratory distress as a complication of influenza.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin (crestor) | 20 mg tablets once daily x max 28 days or for an additional 3 days following ICU discharge |
| DRUG | Placebo | Placebo tablet identical to active therapy. 1 tablet per day |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2009-09-02
- Last updated
- 2017-03-22
- Results posted
- 2013-04-24
Locations
21 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00970606. Inclusion in this directory is not an endorsement.